NHLBI awards $68 million to fund clinical centers in pediatric heart disease

The National Heart, Lung, and Blood Institute (NHLBI), one of the National Institutes of Health (NIH), has awarded grants to four centers to accelerate research aimed at understanding heart development and treating pediatric heart disease.

The research is part of a new program, the Specialized Centers of Clinically Oriented Research (SCCOR) program, which is designed to foster multidisciplinary collaborations so that basic research advances are rapidly translated to clinical care. This research also supports the NIH roadmap initiative unveiled last fall by NIH Director Elias A. Zerhouni, M.D.

"These centers address a critical public health need for research that examines the basis of congenital and acquired heart disease in children," said Acting NHLBI Director Barbara Alving, M.D. "By understanding the choreography of molecular events that creates a four-chambered organ with valves, vessels, and electrical wiring, we can hope to better prevent, diagnose and treat pediatric heart disorders," she added.

Birth defects are a leading cause of infant mortality. Cardiovascular malformations, which are present in approximately one percent of live births, are the largest contributor to deaths from birth defects. Despite the enormous strides researchers have made in understanding heart development at the cellular level, in many cases the underlying cause of the cardiovascular defect is unknown. And while clinical advances have made medical and surgical treatment of complex heart defects possible in the tiniest of infants, the survivors still face numerous challenges.

"If we can improve the odds of these children surviving-and increase their quality of life-then this program will have been a success," said Gail Pearson, M.D., Sc.D., leader of the NHLBI's Heart Development, Function and Failure Scientific Research Group.

Pearson noted that February 14 is Congenital Heart Defects Awareness Day. This national awar

Contact: NHLBI Communications Office
NIH/National Heart, Lung, and Blood Institute

Page: 1 2 3

Related biology news :

1. NHLBI study finds improved heart failure survival
2. NHLBI launches innovative proteomics centers
3. NHLBI study finds DASH diet and reduced sodium lowers blood pressure for all
4. NHLBI supported study finds inhaled steroids accelerate bone loss in women with asthma -- treatment still recommended for persistent asthma
5. NHLBI unveils new resources to help consumers control their blood pressure
6. NHLBI study shows reduced fat intake to lower cholesterol is safe and beneficial for children
7. Reducing sodium leads to substantial drop in blood pressure, finds NHLBI study
8. NHLBI launches genomic applications initiative -- $37 million awarded in initial effort
9. Two NHLBI studies confirm finding of gene in primary pulmonary hypertension
10. NHLBI study shows large blood pressure benefit from reduced dietary sodium
11. Chemical engineering grad students will take notable national awards

Post Your Comments:

(Date:6/5/2020)... ... ... “Although we are disappointed to have to make this decision our primary ... We remain committed to creating a global platform to showcase the science, and ... of WMIS. , The abstract deadline for the virtual meeting is ...
(Date:6/2/2020)... ... June 02, 2020 , ... ... barcode and RFID labeling software developer and solutions provider, today reported that ... improved labeling accuracy and compliance by 100%, resulting in greater efficiency for ...
(Date:5/28/2020)... (PRWEB) , ... May 27, 2020 , ... CrucialTrak, a ... partner with New Jersey-based Critical Environments Group (CEG) to market and sell its complete ... of data center and IT environment infrastructure optimization solutions . , Brett ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... ... (PTU) is commonly used to suppress pigment formation in zebrafish embryos, maintaining optical ... team led by Dr MA has been using the zebrafish model to investigate ...
(Date:7/7/2020)... ... 06, 2020 , ... R3 International is now offering stem cell therapy for ... cells. Depending on the patient's condition, treatment may be offered IV, intrathecal or with ... form of Alzheimers dementia, and the incidence continues to increase as individuals live longer. ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... growth of 40% in 2020, despite many obstacles created as a result of ... increase revenue for its partnered medical practices and medical manufacturers by expanding access ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... launch of a new clinical diagnostics immuno-oncology service, TissueInsight . TissueInsight ... , “Flagship’s TissueInsight is a service that aids pathologists, oncologists, and immunologists ...
Breaking Biology Technology:
Cached News: